Cerebrospinal fluid CXCL13 is a prognostic marker for aseptic meningitis
Authors:
- 1 August 2014
- journal article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 273 (1-2) , 77-84
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- CXCL13 is a biomarker of inflammation in multiple sclerosis, neuromyelitis optica, and other neurological conditionsMultiple Sclerosis Journal, 2013
- Cerebrospinal fluid CXCL13 in Lyme neuroborreliosis and asymptomatic HIV infectionBMC Neurology, 2013
- Cerebrospinal Fluid IL-12p40, CXCL13 and IL-8 as a Combinatorial Biomarker of Active Intrathecal InflammationPLOS ONE, 2012
- Ostre rozsiane zapalenie mózgu i rdzenia kręgowego u dzieci jako następstwo jałowego zapalenia opon mózgowo-rdzeniowych – opis dwóch przypadkówNeurologia i Neurochirurgia Polska, 2011
- Aseptic meningitis as initial presentation of acute disseminated encephalomyelitisJournal of the Neurological Sciences, 2008
- Probable acute disseminated encephalomyelitis due to Haemophilus influenzae meningitisDevelopmental Medicine & Child Neurology, 2008
- Blood–brain barrier impairment in Alzheimer diseaseNeurology, 2007
- Cytokines and chemokines in cerebrospinal fluid and serum of adult patients with acute disseminated encephalomyelitisJournal of the Neurological Sciences, 2006
- Cerebrospinal fluid levels of cytokines and soluble tumour necrosis factor receptor in acute disseminated encephalomyelitis.European Journal of Pediatrics, 2002
- Acute disseminated encephalomyelitis in adults: a reappraisal of clinical, CSF, EEG, and MRI findingsJournal of Neurology, 2000